Zydus receives final approval for Amitriptyline Hydrochloride Tablets
From USFDA
Zydus Cadila has received the final approval from the USFDA to market Amitriptyline Hydrochloride Tablets USP in strengths of 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content